Cargando…
Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure
To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart fail...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452295/ https://www.ncbi.nlm.nih.gov/pubmed/34218511 http://dx.doi.org/10.1002/psp4.12676 |
_version_ | 1784570036167376896 |
---|---|
author | Takaoka, Ryota Soejima, Yukako Guro, Sayuri Yoshioka, Hideki Sato, Hiromi Suzuki, Hiroshi Hisaka, Akihiro |
author_facet | Takaoka, Ryota Soejima, Yukako Guro, Sayuri Yoshioka, Hideki Sato, Hiromi Suzuki, Hiroshi Hisaka, Akihiro |
author_sort | Takaoka, Ryota |
collection | PubMed |
description | To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart failure with reduced ejection fraction (HFrEF), reporting changes in heart rate, blood pressure, or ventricular volumes after treatment with carvedilol, metoprolol, bisoprolol, bucindolol, enalapril, aliskiren, or felodipine, were analyzed. Seven cardiac and vasculature function indices were estimated without invasive measurements using models based on appropriate assumptions, and their correlations with the mortality were assessed. Estimated myocardial oxygen consumption, a cardiac load index, correlated excellently with the mortality at 3, 6, and 12 months after treatment initiation, and it explained differences in mortality across the different medications. The analysis based on the present models were reasonably consistent with the hypothesis that the treatment of HFrEF with various medications is due to effectively reducing the cardiac load. Assessment of circulatory physiological parameters by using MBMA would be insightful for quantitative understanding of CHF treatment. |
format | Online Article Text |
id | pubmed-8452295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84522952021-09-27 Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure Takaoka, Ryota Soejima, Yukako Guro, Sayuri Yoshioka, Hideki Sato, Hiromi Suzuki, Hiroshi Hisaka, Akihiro CPT Pharmacometrics Syst Pharmacol Research To characterize and compare various medicines for chronic heart failure (CHF), changes in circulatory physiological parameter during pharmacotherapy were investigated by a model‐based meta‐analysis (MBMA) of circulatory physiology. The clinical data from 61 studies mostly in patients with heart failure with reduced ejection fraction (HFrEF), reporting changes in heart rate, blood pressure, or ventricular volumes after treatment with carvedilol, metoprolol, bisoprolol, bucindolol, enalapril, aliskiren, or felodipine, were analyzed. Seven cardiac and vasculature function indices were estimated without invasive measurements using models based on appropriate assumptions, and their correlations with the mortality were assessed. Estimated myocardial oxygen consumption, a cardiac load index, correlated excellently with the mortality at 3, 6, and 12 months after treatment initiation, and it explained differences in mortality across the different medications. The analysis based on the present models were reasonably consistent with the hypothesis that the treatment of HFrEF with various medications is due to effectively reducing the cardiac load. Assessment of circulatory physiological parameters by using MBMA would be insightful for quantitative understanding of CHF treatment. John Wiley and Sons Inc. 2021-07-16 2021-09 /pmc/articles/PMC8452295/ /pubmed/34218511 http://dx.doi.org/10.1002/psp4.12676 Text en © 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Takaoka, Ryota Soejima, Yukako Guro, Sayuri Yoshioka, Hideki Sato, Hiromi Suzuki, Hiroshi Hisaka, Akihiro Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title | Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title_full | Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title_fullStr | Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title_full_unstemmed | Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title_short | Model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
title_sort | model‐based meta‐analysis of changes in circulatory system physiology in patients with chronic heart failure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452295/ https://www.ncbi.nlm.nih.gov/pubmed/34218511 http://dx.doi.org/10.1002/psp4.12676 |
work_keys_str_mv | AT takaokaryota modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT soejimayukako modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT gurosayuri modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT yoshiokahideki modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT satohiromi modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT suzukihiroshi modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure AT hisakaakihiro modelbasedmetaanalysisofchangesincirculatorysystemphysiologyinpatientswithchronicheartfailure |